High-risk patients with stage 2 HTN (Systolic BP= 160 or higher or Diastolic BP= 100 or higher), evidence-based first line pharmacotherapy is recommended as:

Name *

Email Address *

Your email address will not be published. (We add your Gravatar icon if you have one)

Your Website URL

Anti Spam Captcha *

Please enter the number you see in the green box to the right.

Comment *

Maximum of 4000 chars. (0/4000)

(Fields marked * are mandatory)